Literature DB >> 11546792

p53 Homologue p63 represses epidermal growth factor receptor expression.

H Nishi1, M Senoo, K H Nishi, B Murphy, T Rikiyama, Y Matsumura, S Habu, A C Johnson.   

Abstract

Tumor suppressor p53 has been shown to transactivate epidermal growth factor receptor (EGFR) expression through binding to a putative p53 responsive element in the EGFR promoter between nucleotides -265 and -239 (EGFRp53RE). Isotypes of p63 gene products, recently identified as p53 relatives, have a similar function to transactivate several p53 target gene promoters. However, our results indicate that TAp63gamma has a very low ability to bind to the EGFRp53RE and surprisingly represses both basal EGFR promoter activity and endogenous EGFR expression. Transient transfection assays show that the EGFR promoter region between -348 and -293, containing two Sp1 sites, is crucial for the repression of the EGFR expression by TAp63gamma. Mutations in these Sp1 sites in the reporter constructs result in loss of the TAp63gamma repression effect. We further show that TAp63gamma directly interacts with Sp1 by immunoprecipitation analysis and that TAp63gamma impairs Sp1 binding to the target DNA site in electrophoretic mobility shift assays. These results suggest that TAp63gamma is involved in the regulation of the EGFR gene expression through interactions with basal transcription factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11546792     DOI: 10.1074/jbc.M101241200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Authors:  Pamela Ghioni; Fabrizio Bolognese; Pascal H G Duijf; Hans Van Bokhoven; Roberto Mantovani; Luisa Guerrini
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  FIH-1 engages novel binding partners to positively influence epithelial proliferation via p63.

Authors:  Nihal Kaplan; Ying Dong; Sijia Wang; Wending Yang; Jong Kook Park; Junyi Wang; Elaina Fiolek; Bethany Perez White; Navdeep S Chandel; Han Peng; Robert M Lavker
Journal:  FASEB J       Date:  2019-11-25       Impact factor: 5.191

Review 3.  Splitting p63.

Authors:  Hans van Bokhoven; Han G Brunner
Journal:  Am J Hum Genet       Date:  2002-05-30       Impact factor: 11.025

4.  PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.

Authors:  P Klanrit; P Taebunpakul; M B Flinterman; E W Odell; M A Riaz; G Melino; P Salomoni; J S Mymryk; J Gäken; F Farzaneh; M Tavassoli
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

5.  Notch-1 regulates transcription of the epidermal growth factor receptor through p53.

Authors:  Benjamin W Purow; Tilak K Sundaresan; Michael J Burdick; Benjamin A Kefas; Laurey D Comeau; Michael P Hawkinson; Qin Su; Yuri Kotliarov; Jeongwu Lee; Wei Zhang; Howard A Fine
Journal:  Carcinogenesis       Date:  2008-03-20       Impact factor: 4.944

6.  ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.

Authors:  Yiping Huang; Tanusree Sen; Jatin Nagpal; Sunil Upadhyay; Barry Trink; Edward Ratovitski; David Sidransky
Journal:  Cell Cycle       Date:  2008-09-15       Impact factor: 4.534

Review 7.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

8.  Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.

Authors:  Laura N Burga; Hai Hu; Ashish Juvekar; Nadine M Tung; Susan L Troyan; Erin W Hofstatter; Gerburg M Wulf
Journal:  Breast Cancer Res       Date:  2011-03-11       Impact factor: 6.466

9.  DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.

Authors:  Alexey V Danilov; Divas Neupane; Archana Sidalaghatta Nagaraja; Elena V Feofanova; Leigh Ann Humphries; James DiRenzo; Murray Korc
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

10.  Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.

Authors:  Barbara Testoni; Roberto Mantovani
Journal:  Nucleic Acids Res       Date:  2006-02-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.